May 20, 2017

Searching online for health-related information by people suffering from respiratory allergy and asthma: the results of a survey study

Anna Kłak, Filip Raciborski, Bolesław Samoliński

Abstract

INTRODUCTION:
The objective of the study was to compare online behaviour in groups of persons suffering from respiratory allergy and/or asthma and in the reference group.

May 19, 2017

Association of Oral Antireflux Medication With Laryngopharyngeal Reflux and Nasal Resistance

Question  Is laryngopharyngeal reflux associated with nasal resistance, and does pharmacologic therapy improve subjective and objective nasal findings?
Findings  This case-control study of 100 adults (50 with laryngopharyngeal reflux, 50 controls) found that oral antireflux medication was associated with significant decreases in all parameters of the Nasal Obstruction Symptom Evaluation and Total Nasal Resistance values.

eHealth in the future of medications management: personalisation, monitoring and adherence

 
OPEN ACCESS
 
OPEN PEER REVIEW


Abstract
Background
Globally, healthcare systems face major challenges with medicines management and medication adherence. Medication adherence determines medication effectiveness and can be the single most effective intervention for improving health outcomes.

May 15, 2017

Sensitization to Aspergillus species is associated with frequent exacerbations in severe asthma


1Department of Respiratory and Critical Care Medicine, Singapore General Hospital, 2Duke-National University of Singapore Medical School, 3Allergy Centre, Singapore General Hospital, 4Department of Biological Sciences, Faculty of Science, National University of Singapore, 5Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore

*These authors contributed equally to this work


Background: Severe asthma is a largely heterogeneous disease with varying phenotypic profiles. The relationship between specific allergen sensitization and asthma severity, particularly in Asia, remains unclear. We aim to study the prevalence of specific allergen sensitization patterns and investigate their association with outcomes in a severe asthma cohort in an Asian setting.

May 9, 2017

Seasonal influenza vaccination in patients with COPD: a systematic literature review

 
OPEN ACCESS
 
OPEN PEER REVIEW

  • Rafik Bekkat-BerkaniEmail author,
  • Tom Wilkinson,
  • Philippe Buchy,
  • Gael Dos Santos,
  • Dimitris Stefanidis,
  • Jeanne-Marie Devaster and
  • Nadia Meyer
Abstract
Background
Influenza is a frequent cause of exacerbations of chronic obstructive pulmonary disease (COPD). Exacerbations are associated with worsening of the airflow obstruction, hospitalisation, reduced quality of life, disease progression, death, and ultimately, substantial healthcare-related costs. Despite longstanding recommendations to vaccinate vulnerable high-risk groups against seasonal influenza, including patients with COPD, vaccination rates remain sub-optimal in this population.

May 5, 2017

Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study


    1. Previous article in issue: Overview of systematic reviews in allergy epidemiology

    Abstract
    Background
    The use of Apps running on smartphones and tablets profoundly affects medicine. The MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) App (Allergy Diary) assesses allergic rhinitis symptoms, disease control and impact on patients’ lives. It is freely available in 20 countries (iOS and Android platforms).
    Aims

    To assess in a pilot study whether (i) Allergy Diary users were able to properly provide baseline characteristics (ii) simple phenotypic characteristics based upon data captured by the Allergy Diarycould be identified and (iii) information gathered by this study could suggest novel research questions.
    Methods
    The Allergy Diary users were classified into six groups according to the baseline data that they entered into the App: (i) asymptomatic; (ii) nasal symptoms excluding rhinorrhea; (iii) rhinorrhea; (iv) rhinorrhea plus 1–2 nasal/ocular symptoms; (v) rhinorrhea plus ≥3 nasal/ocular symptoms; and (vi) rhinorrhea plus all nasal/ocular symptoms.

Allergists on Social Media